UK markets close in 1 hour 5 minutes

Tandem Diabetes Care, Inc. (0M0F.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
42.77+0.60 (+1.42%)
As of 02:33PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.27
52-week change 3-28.09%
S&P500 52-week change 325.87%
52-week high 343.04
52-week low 313.89
50-day moving average 325.84
200-day moving average 325.68

Share statistics

Avg vol (3-month) 3681
Avg vol (10-day) 3877
Shares outstanding 557.37M
Implied shares outstanding 6N/A
Float 864.01M
% held by insiders 10.75%
% held by institutions 1117.15%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -18.37%
Operating margin (ttm)-21.74%

Management effectiveness

Return on assets (ttm)-9.70%
Return on equity (ttm)-48.63%

Income statement

Revenue (ttm)770.01M
Revenue per share (ttm)11.82
Quarterly revenue growth (yoy)13.20%
Gross profit (ttm)N/A
EBITDA -130.71M
Net income avi to common (ttm)-141.45M
Diluted EPS (ttm)0.09
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)467.81M
Total cash per share (mrq)7.24
Total debt (mrq)477.55M
Total debt/equity (mrq)196.47%
Current ratio (mrq)3.81
Book value per share (mrq)3.77

Cash flow statement

Operating cash flow (ttm)-21.48M
Levered free cash flow (ttm)-44.57M